Teleflex to Unveil New Anesthesia Solutions at Anesthesiology 2012

LIMERICK, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, will showcase several new anesthesia and vascular access products at the American Society of Anesthesiologists (ASA) annual meeting, ANESTHESIOLOGY 2012, October 13-15, 2012, in Washington, D.C., including:

“We are very pleased to be able to unveil these new products to the 12,000 anesthesiologists and healthcare professionals expected to attend this year’s meeting.”

• The Rusch^® EZ-Blocker™ Endobronchial Blocker, an innovative addition to the Teleflex^® airway management portfolio, received 510(k) clearance in September 2012. The EZ-Blocker endobronchial blocker is designed to allow for safer and easier lung isolation and one lung ventilation, both critical procedures performed by anesthesiologists during thoracic surgery.
• The Arrow^® FlexBlock™ Continuous Peripheral Nerve Block Catheter, which received 510(k) clearance in August 2012, is targeted toward clinicians who use ultrasound-guidance when placing continuous peripheral nerve block catheters. The FlexBlock catheter’s unique design offers a combination of ultrasound visibility, flexibility, excellent kink resistance, and a catheter tip designed to provide clinicians with a predictable spread of anesthetic.
• The Arrow^® FlexTip Plus^® Multi-Port Epidural Catheter is designed using the same proven technology of the market-leading¹ FlexTip Plus^® open tip, single-port catheter, which is proven to significantly reduce complications commonly associated with epidural catheters, such as vein cannulations and paresthesia^2-3. With the addition of the closed tip, multi-port catheter, the FlexTip Plus product portfolio now provides the drug dispersion choices clinicians demand. The FlexTip Plus Multi-Port epidural catheter received 510(k) clearance in May 2012.
• The Arrow^® ErgoPack™ System is an ergonomic packaging system for vascular access procedures designed to efficiently facilitate compliance with best practices, evidence-based medicine, guidelines and recommendations from organizations to reduce the risk of Central Line-Associated Bloodstream Infections (CLABSI).

"Teleflex is proud to be an ASA Industry supporter, and we look forward to conversations with anesthesiologists about our new, innovative solutions for efficient and safe patient care," said Cary Vance, President of the Teleflex Anesthesia and Respiratory Division. "We are very pleased to be able to unveil these new products to the 12,000 anesthesiologists and healthcare professionals expected to attend this year’s meeting."

About Teleflex Incorporated

Teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. Our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. Headquartered in Limerick, PA, Teleflex employs approximately 11,200 people worldwide and serves healthcare providers in more than 130 countries. Additional information about Teleflex can be obtained from the company's website at teleflex.com.

Forward-Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.

Arrow, ErgoPack, EZ-Blocker, FlexBlock, FlexTip Plus, Rusch, and Teleflex are trademarks or registered trademarks of Teleflex Incorporated or its affiliates. ©2012 Teleflex Incorporated. All rights reserved. 2012-1443.

References:
	1.	GHX Market Data, FY 2011
	2.	Banwell B.R., Morley-Foster P., Krause B.R. Decreased incidence of complications in parturients with the Arrow (FlexTip Plus) epidural catheter. Canadian Journal of Anesthesia. 1998; 45: 370-372.
	3.	Cohen S, et al. Arrow versus B. Braun Epidural Catheter for Epidural Block in Obstetric Patients. 2004; 101: A1199.